PBGH Announcements

For Media Inquiries:

Lisa Zamosky
(917) 751-0232

November 2, 2021

National Employer Group Praises Drug Deal Announced Today

The Purchaser Business Group on Health (PBGH) commends congressional negotiators who struck a landmark deal to reform the prescription drug market.

October 28, 2021

Statement on the New Budget Reconciliation Framework

The Purchaser Business Group on Health is profoundly disappointed that the budget reconciliation framework announced today by President Biden omits any policies to deal with unaffordable prescription drugs.

October 6, 2021

PBGH Strongly Supports the No Surprises Act Interim Final Rule: A Big Win for Consumers and Employers

On Sept. 30, the Departments of Health and Human Services, Labor and Treasury, released an interim final rule (IFR) implementing the No Surprises Act.

September 30, 2021

Quality Improvement Project to Modernize Primary Care Launched

Covered California, the California Public Employees’ Retirement System (CalPERS) and the Purchaser Business Group on Health (PBGH) are partnering to launch a pilot program to promote improvement in primary care which will benefit all Californians.

September 13, 2021

Patients and Employers Agree: Congress Must Allow Medicare to Negotiate Lower Drug Prices for Americans

Patients and employers urge the House Ways and Means and Energy and Commerce Committees to move forward with H.R. 3, a bill that will empower Medicare to negotiate lower drug prices on behalf of Americans.

September 7, 2021

EmployersRx: Congress Must Reduce Drug Costs for Everyone

Congressional leaders are currently drafting legislation that would allow the federal government to negotiate the price of high-cost drugs and those newly entering the market.

August 31, 2021

Final Approval Granted for the Sutter Health Settlement

The settlement agreement achieved in the Sutter Health case, along with the injunctive relief, will have a significant and beneficial economic impact.

August 12, 2021

PBGH Statement on President Biden’s Remarks on Lowering Drug Costs

Addressing health care costs, and in particular the cost of prescription drugs, is an economic issue. Earnings siphoned off by health care costs limit job creation and wage growth, divert investment and cripple competitiveness and innovation.

July 19, 2021

PBGH Statement in Response to CMS Raising Penalties for Hospitals Failing to Make Prices Public

We are very pleased that the Biden administration is signaling its intention to aggressively implement the previous administration’s hospital price transparency rule.

July 15, 2021

Purchaser Business Group on Health Appoints Four New Members to Its Board of Directors

The Purchaser Business Group on Health (PBGH) has announced the addition of four new board members.